Controlled trial of ancrod in ischemic stroke.


Phase N/A Results

Eligibility Criteria

Inclusion Criteria

Acute ischemic stroke presenting within 48 hours of onset.

Exclusion Criteria

Intracranial mass bleeding or extensive hemorrhagic infarction by computed tomographic (CT) scan; evidence of acute myocardial infarction during the previous three weeks, malignant hypertension, or hepatic or renal insufficiency; previous treatment with anticoagulant or antiplatelet drugs.